Needs and preferences for psychological interventions of people with motor neuron diseaseKirsty Weeks, Vanessa Lawrence, Lance M. McCracken et al.|Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration|2019Cited by 39
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, Massimo Locati, P. Nigel Leigh et al.|The Lancet|2025Cited by 33
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UKRebecca L. Gould, Jessica Marsh, Christopher McDermott et al.|The Lancet|2024Cited by 30